Chao David M Insider Trades

Insider Trading History

Track insider trading activity for Chao David M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Administrative Officer
Holding Value $9.03M 226,529 shares
Last Trade
Mar 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$120k 7,000 shares
$17.17
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Administrative Officer
Holding Value $4.44M 111,500 shares
Last Trade
Mar 17, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$60.2k 3,500 shares
$17.20
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Administrative Officer
Holding Value $9.25M 232,007 shares
Last Trade
Mar 17, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$60.2k 3,500 shares
$17.20
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Administrative Officer
Holding Value $9.11M 228,507 shares
Last Trade
Feb 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$225k 13,324 shares
$16.92
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Administrative Officer
Holding Value $9.64M 241,831 shares
Last Trade
Dec 31, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$170k 10,385 shares
$16.35
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Administrative Officer
Holding Value $10.1M 252,216 shares
Last Trade
Sep 30, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$164k 10,385 shares
$15.79
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Administrative Officer
Holding Value $10.5M 262,601 shares
Last Trade
Jun 30, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$93.8k 10,385 shares
$9.03
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Administrative Officer
Holding Value $10.9M 272,986 shares
Last Trade
Mar 31, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$117k 10,385 shares
$11.30
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Administrative Officer
Holding Value $11.3M 283,371 shares
Last Trade
Feb 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$77.8k 9,503 shares
$8.19
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Administrative Officer
Holding Value $11.7M 292,874 shares
Last Trade
Feb 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.2M 150,000 shares
$8.01
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Administrative Officer
Holding Value $10.2M 255,374 shares
Last Trade
Dec 31, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$82.9k 10,419 shares
$7.96
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Administrative Officer
Holding Value $10.6M 265,793 shares
Last Trade
Sep 30, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$67.4k 10,419 shares
$6.47
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Administrative Officer
Holding Value $11M 276,212 shares
Last Trade
Jun 30, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$61.5k 10,419 shares
$5.90
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Administrative Officer
Holding Value $11.4M 286,631 shares
Last Trade
Mar 31, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$27.2k 6,969 shares
$3.90
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Administrative Officer
Holding Value $11.7M 293,600 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$443k 115,000 shares
$3.85
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Administrative Officer
Holding Value $8.99M 225,611 shares
Last Trade
Dec 31, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$15.2k 4,889 shares
$3.10
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Administrative Officer
Holding Value $8.88M 222,932 shares
Last Trade
Oct 03, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.5k 4,167 shares
$3.95
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Administrative Officer
Holding Value $9.05M 227,099 shares
Last Trade
Sep 30, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$13.8k 3,401 shares
$4.07
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Administrative Officer
Holding Value $8.82M 221,289 shares
Last Trade
Sep 30, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$39.1k 9,211 shares
$4.25
$39.85
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc CNTA
Chief Administrative Officer
Holding Value $9.19M 230,500 shares
Last Trade
Jul 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.19M 230,000 shares
$5.17
$39.85

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up